2/17
10:56 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/17
10:48 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/17
10:48 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/17
07:01 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
2/13
02:19 pm
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/13
02:19 pm
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/13
01:05 pm
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
2/13
01:05 pm
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
2/13
12:52 pm
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/13
12:52 pm
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/13
12:15 pm
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/13
11:12 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "outperform" rating reaffirmed by analysts at Scotiabank.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "outperform" rating reaffirmed by analysts at Scotiabank.
2/13
11:12 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "outperform" rating reaffirmed by analysts at Scotiabank.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "outperform" rating reaffirmed by analysts at Scotiabank.
2/13
10:16 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
2/13
10:16 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.
2/13
10:07 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/13
10:07 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/13
08:00 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Oppenheimer Holdings, Inc. from a "market perform" rating to an "outperform" rating. They now have a $540.00 price target on the stock.
Medium
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Oppenheimer Holdings, Inc. from a "market perform" rating to an "outperform" rating. They now have a $540.00 price target on the stock.
2/13
07:52 am
vrtx
Vertex Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer
Medium
Report
Vertex Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer
2/13
07:52 am
vrtx
Vertex Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer
Medium
Report
Vertex Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer
2/13
07:17 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
1/28
09:55 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
1/28
09:55 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
1/27
05:02 pm
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.
1/26
12:55 pm
vrtx
Rating for VRTX
Low
Report
Rating for VRTX